Approval · Notice of Compliance 25629 · 2021

ZOCOR: Notice of Compliance 25629

Issued April 8, 2021

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 25629
Date: April 8, 2021
Company: Organon Canada Inc.Kirkland, Quebec, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Reason: Change in product ownership

Products in this notice

Brand	DIN	Status today
ZOCOR	00884332	Marketed
ZOCOR	00884340	Marketed
ZOCOR	00884359	Marketed

Medicinal ingredients

SIMVASTATIN 10 MG per TAB
SIMVASTATIN 20 MG per TAB
SIMVASTATIN 40 MG per TAB